Gurney Jennifer, Philbin Nora, Rice Jennifer, Arnaud Françoise, Dong Feng, Wulster-Radcliffe Meghan, Pearce L Bruce, Kaplan Lewis, McCarron Richard, Freilich Daniel
Walter Reed Army Medical Center (J.G.), Washington, DC, USA.
J Trauma. 2004 Oct;57(4):726-38. doi: 10.1097/01.ta.0000147520.84792.b4.
As HBOC-201 improves outcome in animals with hemorrhagic shock (HS), we compared HBOC-201 and HEX (used by U.S. military special operations forces) in a swine model of delayed evacuation and uncontrolled HS.
Twenty-four Yucatan pigs underwent a grade III liver injury and were resuscitated with HBOC-201, HEX, or no fluid (NON). Additional infusions were given for hypotension or tachycardia. After 4 hours, the liver was repaired; IV fluids and blood transfusions were administered. Pigs were monitored for 72 hours.
Survival was 7/8, 1/8, and 1/8 in HBOC-201-, HEX-, and NON-resuscitated pigs, respectively. Compared with HEX, HBOC-201 pigs had higher systemic and pulmonary artery pressures and had comparable cardiac outputs, but were less tachycardic. Transcutaneous tissue oxygenation was restored more rapidly in HBOC-201 pigs, there was a trend to lower lactic acid, and base deficit was less. HBOC-201 pigs had lower fluid requirements, higher urine output, and lower blood loss than HEX pigs.
Despite evidence of vasoactivity, HBOC-201 more effectively stabilized tissue oxygenation, reversed anaerobic metabolism, decreased bleeding, and increased survival in comparison with HEX. If confirmed in clinical trials, these data suggest that for the resuscitation of combat casualties with delayed evacuation and uncontrolled HS due to solid organ injury, HBOC-201 is a superior low-volume resuscitative fluid.
由于HBOC-201可改善失血性休克(HS)动物的预后,我们在猪延迟后送和未控制的HS模型中比较了HBOC-201和HEX(美国军事特种作战部队使用)。
24只尤卡坦猪接受III级肝损伤,并用HBOC-201、HEX或不输液(NON)进行复苏。针对低血压或心动过速给予额外输注。4小时后,修复肝脏;给予静脉输液和输血。对猪进行72小时监测。
接受HBOC-201、HEX和NON复苏的猪的存活率分别为7/8、1/8和1/8。与HEX相比,接受HBOC-201复苏的猪的体循环和肺动脉压更高,心输出量相当,但心动过速程度较轻。接受HBOC-201复苏的猪经皮组织氧合恢复更快,乳酸有降低趋势,碱缺失更少。与接受HEX复苏的猪相比,接受HBOC-201复苏的猪液体需求量更低,尿量更高,失血量更少。
尽管有血管活性证据,但与HEX相比,HBOC-201能更有效地稳定组织氧合,逆转无氧代谢,减少出血并提高存活率。如果在临床试验中得到证实,这些数据表明,对于因实体器官损伤导致延迟后送和未控制的HS的战斗伤员复苏,HBOC-201是一种更优的小容量复苏液。